Cost-Effectiveness of Using LDL-Direct Versus Lipid-Panel as Part of the Inpatient Stroke Workup

As part of the investigation for the etiology of ischemic stroke or transient ischemic attack, assessing for modifiable risk factors has become standard practice. One such risk factor is dyslipidemia. The current practice to assess for dyslipidemia is to obtain the low-density-lipoprotein cholesterol (LDL-C) through serology, either by ordering a lipid panel or by ordering a direct LDL in order to obtain a more precise measurement.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Source Type: research